国际帕金森病和运动障碍大会®
Past Event
海报
The Effect of Modulating Alpha-synuclein Aggregation on Clinical Outcome in the Presence of Standard-of-care Dopaminergic Therapy in Parkinson’s Disease. A Quantitative Systems Pharmacology Approach
Presenter: Hugo Geerts, PhD, Head QSP Neurosciences, Certara